Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
639 studies found for:    "ulcerative colitis"
Show Display Options
Rank Status Study
1 Terminated Basiliximab Maintenance in Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Basiliximab
2 Active, not recruiting Special Investigation in Patients With Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention:
3 Completed Wireless Capsule Endoscopy in Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Device: Given® Diagnostic System
4 Terminated Effects of Probiotics in Patients With Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Dietary Supplement: Kyo-Dophilus;   Dietary Supplement: placebo
5 Withdrawn Lactobacillus GG in Pediatric Ulcerative Colitis (UC)
Condition: Ulcerative Colitis
Intervention: Biological: Lactobacillus GG
6 Completed Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC)
Condition: Ulcerative Colitis
Intervention:
7 Completed Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: COLAL-PRED®;   Drug: Prednisolone
8 Completed Basiliximab in Moderate to Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Basiliximab
9 Completed
Has Results
A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Biological: adalimumab;   Drug: placebo
10 Completed Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: ASP3291;   Drug: Placebo
11 Completed Treatment of Ulcerative Colitis With Ciprofloxacin and E. Coli Nissle
Condition: Ulcerative Colitis
Interventions: Drug: Ciprofloxacin;   Dietary Supplement: E. coli Nissle
12 Active, not recruiting Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Biological: adalimumab
13 Completed Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: AVX 470;   Drug: Placebo
14 Enrolling by invitation Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Biological: Adalimumab
15 Recruiting Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects With Moderate to Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: Adalimumab;   Other: Placebo
16 Completed Study for the Treatment of Ulcerative Colitis With Adacolumn
Condition: Ulcerative Colitis
Intervention: Device: Adacolumn Apheresis System
17 Active, not recruiting AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Biological: AMG 181;   Other: Placebo
18 Terminated Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis; Efficacy, Safety and Tolerability Study
Condition: Ulcerative Colitis
Interventions: Drug: Propionyl-L-Carnitine;   Drug: Placebo
19 Completed (CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis.
Condition: Ulcerative Colitis
Interventions: Drug: Budesonide MMX 6 mg Tablet;   Drug: Placebo Tablet
20 Completed A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Biological: sterile saline for injection;   Biological: MDX-1100

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.